According to a new report, lung cancer patients live longer while on immune therapy.
Using a combination of immunotherapy drugs, doctors found that pre-treating lung cancer patients before surgery can help eat away at tumors, while helping patients recover from the affects of chemotherapy.
A lung cancer specialist at Yale Cancer Center, who was not involved with the study, stated the results are so startling, every lung cancer patient should be given the option of immunotherapy first..
According to Business Insider, "New cancer treatments that harness the body's immune system are ready to go mainstream... cancer drugmakers showed that the use of immunotherapy in combination with.. Source: Wochit News -